Embolic protection in carotid artery stenting: New options

Techniques in Vascular and Interventional Radiology

Volumn 14, Issue 2, 2011, Pages 86-94

  Metzger, D Christopher ^a  

^a Wellmont CVA Heart Institute   (United States)

Author keywords

Activated clotting time; Carotid artery stenting; Carotid endarterectomy; Center for MediCare and MediCaid Services; Common carotid artery; Embolic protection device; External carotid artery; Internal carotid artery; Major adverse events

Indexed keywords

ANGIOGRAPHY; AORTA ARCH; ARTERY CATHETER; ARTICLE; ASPIRATION; CAROTID ARTERY STENTING; COMMON CAROTID ARTERY; DISTAL EMBOLIC PROTECTION DEVICE; DISTAL EMBOLIZATION; EMBOLIC PROTECTION DEVICE; EMBOLISM; EMBOLISM PREVENTION; EXPERIENCE; HIGH RISK PATIENT; HUMAN; INTERNAL CAROTID ARTERY; MEDICAL PRACTICE; NONSURGICAL INVASIVE THERAPY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SELECTION; PRACTICE GUIDELINE; PROTECTIVE EQUIPMENT; ANGIOPLASTY; CAROTID ARTERY DISEASE; INSTRUMENTATION; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STENT; TREATMENT OUTCOME;

ANGIOPLASTY; CAROTID ARTERY DISEASES; EMBOLIC PROTECTION DEVICES; EMBOLISM; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 79960761996     PISSN: 10892516     EISSN: 15579808     Source Type: Journal    
DOI: 10.1053/j.tvir.2011.01.006     Document Type: Article

References (15)

1. American Heart Association: Heart Disease and Stroke Statistics, 2004 update. Available at http://www.americanheart.org/downloadable/heart/1079736729696HDSStats2004Update REV. 3/19/04. pdf
2. Debakey MH: Carotid endarterectomy revisited. J Endovasc Surg 3:4, 1996
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of CEA in symptomatic patients and high-grade carotid stenoses. N Engl J Med 325:445-453, 1991
4. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421-1428, 1995
5. Randomized Trial of Endarterectomy for Recently Symptomatic Carotid Stenosis: Final results of the MRC European carotid surgery trial (ECST). Lancet 351:379-387, 1998
6. Yadav JS, Wholey MH, Kuntz RE, et al: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493-1501, 2004
7. Gray WA, Hopkins LN, Yadav J, et al: Protected carotid stenting in highsurgical-risk patients: the ARCHeR results. J Vasc Surg 49:258-269, 2006
8. CREST, Brott TG, Hobson RW, et al: Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 363:11-23, 2010
9. Roubin GS, Iyer S, Halkin A, et al: Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation 113:2021-2030, 2006
10. White CJ, Metzger DC, Ansel GM, et al: Safety and efficacy of carotid stenting in the very elderly. Catheter Cardiovasc Interv 75:651-655, 2010
11. Ansel GM, Hopkins LN, Jaff MR, et al: Safety and effectiveness of the INVATEC MO. MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv 76:1-8, 2010
12. Hopkins LN: The EMPIRE trial results: Presented at TCT, October 17, 2008. Washington, DC
13. Chaturedi S, Gray WA, Matsumara J. Safety outcomes for the PROTECT Carotid Artery Stenting Multicenter Study. Stroke 40:2, 2009
14. Myla S, Bacharach JM, Ansel GM, et al: Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: the EPIC trial results. Catheter Cardiovasc Interv 75:817-822, 2010
15. Massop D, Dave R, Metzger C, et al: Stenting and angioplasty with protection in patients at high-risk for Endarterectomy: SAPPHIRE World-Wide Registry in the First 2,001 patients. Catheter Cardiovasc Interv 73:129-136, 2009